Clinical trial

A Study of ADH300004 in Surgically Resected Primary or Metastatic Colorectal…

NCT00264446 · Adherex Technologies, Inc., Industry · Completed

Key facts

NCT number NCT00264446
Title A Study of ADH300004 in Surgically Resected Primary or Metastatic Colorectal Cancer and Liver Biopsy, or Planned Hepatic Resection
Official title Phase 1 Study of the Evaluation of Dihydropyrimidine Dehydrogenase (DPD), Uridine Phosphorylase (UP), Orotate Phosphoribosyl Transferase (OPRT), and Thymidine Phosphorylase (TP) Activity in Tissue Resected From Subjects Undergoing Planned Resection of Primary or Metastatic Colorectal Cancer and…
Lead sponsor Adherex Technologies, Inc., Industry
Status Completed
Phase Phase 1
Study type Interventional
Conditions Neoplasms
Intervention type Drug
Interventions ADH300004
First posted Dec 13, 2005
Last update posted Aug 6, 2007
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies